Td Asset Management Inc Seer, Inc. Transaction History

Td Asset Management Inc

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 27, 2023	BUY	$2.18 - $5.52 $191,168 - $484,059	87,692 Added 100.0%	175,384 $387,000
Q1 2023 May 10, 2023	SELL	$3.6 - $5.88 $88,704 - $144,883	-24,640 Reduced 21.93%	87,692 $338,000
Q4 2022 Feb 06, 2023	SELL	$5.03 - $8.58 $73,438 - $125,268	-14,600 Reduced 11.5%	112,332 $651,000
Q2 2022 Aug 04, 2022	SELL	$6.72 - $16.07 $461,341 - $1.1 Million	-68,652 Reduced 35.1%	126,932 $1.14 Million
Q1 2022 May 10, 2022	SELL	$11.88 - $23.4 $613,435 - $1.21 Million	-51,636 Reduced 20.89%	195,584 $2.98 Million
Q4 2021 Feb 10, 2022	SELL	$21.08 - $38.51 $77,700 - $141,947	-3,686 Reduced 1.47%	247,220 $5.64 Million
Q3 2021 Nov 09, 2021	BUY	$27.67 - $45.04 $221,360 - $360,320	8,000 Added 3.29%	250,906 $8.66 Million
Q2 2021 Aug 11, 2021	BUY	$28.75 - $56.92 $5.04 Million - $9.97 Million	175,224 Added 258.89%	242,906 $7.76 Million
Q1 2021 May 14, 2021	BUY	$38.67 - $84.06 $1.62 Million - $3.53 Million	41,998 Added 163.52%	67,682 $3.39 Million
Q4 2020 Feb 16, 2021	BUY	$55.23 - $81.11 $1.42 Million - $2.08 Million	25,684 New	25,684 $1.44 Million

39.7M

100

100

Ticker SEER
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,566,500
Market Cap $115M
Description
Seer, Inc., a life sciences company, engages in developing and commercializing products to decode the secrets of the proteome. It develops Proteograph Product Suite, an integrated solution that comprises consumables, an automation instrumentation, and software that allows researchers to conduct proteomic studies in therapeutic and diagnostic res...

Get notified when there are updates to the investment portfolio of Td Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Td Asset Management Inc with notifications on news.